skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 30,296  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
COVID-19 and ethnicity: who will research results apply to?
Material Type:
Article
Add to My Research

COVID-19 and ethnicity: who will research results apply to?

The Lancet (British edition), 2020-06, Vol.395 (10242), p.1955-1957 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31380-5 ;PMID: 32539937

Full text available

2
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape
Material Type:
Article
Add to My Research

The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape

PLoS biology, 2021-04, Vol.19 (4), p.e3000959-e3000959 [Peer Reviewed Journal]

2021 Fraser et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Fraser et al 2021 Fraser et al ;ISSN: 1545-7885 ;ISSN: 1544-9173 ;EISSN: 1545-7885 ;DOI: 10.1371/journal.pbio.3000959 ;PMID: 33798194

Full text available

3
The impact of the COVID-19 pandemic response on other health research
Material Type:
Article
Add to My Research

The impact of the COVID-19 pandemic response on other health research

Bulletin of the World Health Organization, 2020-09, Vol.98 (9), p.625-631 [Peer Reviewed Journal]

(c) 2020 The authors; licensee World Health Organization. ;Copyright World Health Organization Sep 2020 ;(c) 2020 The authors; licensee World Health Organization. 2020 ;ISSN: 0042-9686 ;EISSN: 1564-0604 ;DOI: 10.2471/BLT.20.257485 ;PMID: 33012862

Full text available

4
Will COVID-19 be evidence-based medicine's nemesis?
Material Type:
Article
Add to My Research

Will COVID-19 be evidence-based medicine's nemesis?

PLoS medicine, 2020-06, Vol.17 (6), p.e1003266-e1003266 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003266 ;PMID: 32603323

Full text available

5
Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreak
Material Type:
Article
Add to My Research

Mapping the situation of research on coronavirus disease-19 (COVID-19): a preliminary bibliometric analysis during the early stage of the outbreak

BMC infectious diseases, 2020-08, Vol.20 (1), p.561-8, Article 561 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2334 ;EISSN: 1471-2334 ;DOI: 10.1186/s12879-020-05293-z ;PMID: 32738881

Full text available

6
Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19
Material Type:
Article
Add to My Research

Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19

PLoS pathogens, 2020-10, Vol.16 (10), p.e1008902-e1008902 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Kinsella et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Kinsella et al 2020 Kinsella et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1008902 ;PMID: 33035262

Full text available

7
Covid-19: What do we know about “long covid”?
Material Type:
Article
Add to My Research

Covid-19: What do we know about “long covid”?

BMJ (Online), 2020-07, Vol.370, p.m2815-m2815 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2020BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m2815

Full text available

8
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Material Type:
Article
Add to My Research

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Nature (London), 2021-08, Vol.596 (7871), p.276-280 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Aug 12, 2021 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03777-9 ;PMID: 34237773

Full text available

9
A clinical case definition of post-COVID-19 condition by a Delphi consensus
Material Type:
Article
Add to My Research

A clinical case definition of post-COVID-19 condition by a Delphi consensus

The Lancet infectious diseases, 2022-04, Vol.22 (4), p.e102-e107 [Peer Reviewed Journal]

2022 World Health Organization. Published by Elsevier Ltd.All rights reserved ;Copyright © 2022 World Health Organization. Published by Elsevier Ltd.All rights reserved. Published by Elsevier Ltd.. All rights reserved. ;2022. World Health Organization. Published by Elsevier Ltd.All rights reserved ;2022 World Health Organization. Published by Elsevier Ltd.All rights reserved 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00703-9 ;PMID: 34951953

Full text available

10
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study
Material Type:
Article
Add to My Research

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

The Lancet infectious diseases, 2022-09, Vol.22 (9), p.1293-1302 [Peer Reviewed Journal]

2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2022 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00320-6 ;PMID: 35753318

Full text available

11
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
Material Type:
Article
Add to My Research

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

New England Journal of Medicine, 2021-06, Vol.384 (23), p.2259-2261 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103916 ;PMID: 33822494

Digital Resources/Online E-Resources

12
Global cancer research in the post-pandemic world
Material Type:
Article
Add to My Research

Global cancer research in the post-pandemic world

The lancet oncology, 2021-12, Vol.22 (12), p.1652-1654 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00602-1 ;PMID: 34856137

Full text available

13
Heavily mutated Omicron variant puts scientists on alert
Material Type:
Article
Add to My Research

Heavily mutated Omicron variant puts scientists on alert

Nature (London), 2021-12, Vol.600 (7887), p.21-21 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 2, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03552-w

Full text available

14
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Material Type:
Article
Add to My Research

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

New England Journal of Medicine, 2021-05, Vol.384 (20), p.1899-1909 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2103055 ;PMID: 33951374

Digital Resources/Online E-Resources

15
Reboot biomedical R&D in the global public interest
Material Type:
Article
Add to My Research

Reboot biomedical R&D in the global public interest

Nature (London), 2022-02, Vol.602 (7896), p.207-210 [Peer Reviewed Journal]

Copyright Nature Publishing Group Feb 10, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-022-00324-y ;PMID: 35140380

Full text available

16
Cytokine Storm
Material Type:
Article
Add to My Research

Cytokine Storm

New England Journal of Medicine, 2020-12, Vol.383 (23), p.2255-2273 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2026131 ;PMID: 33264547

Digital Resources/Online E-Resources

17
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
Material Type:
Article
Add to My Research

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

Nature medicine, 2021-05, Vol.27 (5), p.790-792 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01316-7 ;PMID: 33782619

Full text available

18
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Material Type:
Article
Add to My Research

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

The Lancet Oncology, 2020-03, Vol.21 (3), p.335-337 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30096-6 ;PMID: 32066541

Digital Resources/Online E-Resources

19
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Material Type:
Article
Add to My Research

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

New England Journal of Medicine, 2021-09, Vol.385 (12), p.1078-1090 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2110475 ;PMID: 34432976

Digital Resources/Online E-Resources

20
BEYOND OMICRON: WHAT'S NEXT FOR SARS-COV-2 EVOLUTION
Material Type:
Article
Add to My Research

BEYOND OMICRON: WHAT'S NEXT FOR SARS-COV-2 EVOLUTION

Nature (London), 2021-12, Vol.600 (7888), p.204-207 [Peer Reviewed Journal]

Copyright Nature Publishing Group Dec 9, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03619-8

Full text available

Results 1 - 20 of 30,296  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2020  (1)
  2. 2020 To 2020  (9,854)
  3. 2021 To 2021  (11,559)
  4. 2022 To 2023  (8,755)
  5. After 2023  (128)
  6. More options open sub menu

Subject 

  1. Medical Research  (30,131)
  2. Covid-19  (24,477)
  3. Pandemics  (11,654)
  4. Covid-19 Vaccines  (9,585)
  5. Infections  (9,103)
  6. Disease Transmission  (8,063)
  7. Science & Technology  (6,683)
  8. Vaccines  (5,940)
  9. Antibodies  (5,887)
  10. Viruses  (5,867)
  11. Life Sciences & Biomedicine  (5,531)
  12. Laboratories  (4,069)
  13. Public Health  (4,001)
  14. Clinical Trials  (3,805)
  15. Patients  (3,802)
  16. Infectious Diseases  (3,672)
  17. Proteins  (3,585)
  18. Researchers  (3,480)
  19. More options open sub menu

Language 

  1. English  (30,274)
  2. Japanese  (519)
  3. Portuguese  (29)
  4. Spanish  (21)
  5. Urdu  (15)
  6. Turkish  (15)
  7. Norwegian  (11)
  8. French  (10)
  9. Chinese  (8)
  10. Polish  (2)
  11. German  (2)
  12. Russian  (1)
  13. Indonesian  (1)
  14. Italian  (1)
  15. Hindi  (1)
  16. More options open sub menu

Searching Remote Databases, Please Wait